Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07315204 · ClinicalTrials.gov registry record
Viability Assessment Using FMN Measured in Perfusate and Bile During Normothermic Machine Perfusion
A clinical trial of Liver Transplant Disorder, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 850
- Enrollment target
- 1
- Study location
NCT07315204 is a study of Liver Transplant Disorder that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 850 participants, above the 28-participant average among 3 other Liver Transplant Disorder trials with a reported enrollment target (2936% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07315204, a study of Liver Transplant Disorder, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 850 participants
- Enrollment target
- 1
- Study location
Study Summary
Discarded perfusate samples will be collected from donors after circulatory death (DCD) or donors after brain death (DBD) organs during the machine perfusion period prior to transplantation by the study team. FMN will be measured as is standard of care for all machine perfusion liver transplant cases at Cleveland Clinic. Participating centers will be provided with sample collection and shipping instructions to ensure sample preservation in accordance with IATA guidelines. Samples from outside sites will not be stored for future research and will be discarded once analysis is completed. After the collection of the samples from machine perfusion, the transplant procedure will continue according to standard process.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2025-12-29 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07315204
The ClinicalTrials.gov registry entry for NCT07315204 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 850 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 28-participant average among 3 other Liver Transplant Disorder trials with a reported enrollment target (2936% higher). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplant Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT07315204 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07315204 about?
NCT07315204 is a clinical study titled "Viability Assessment Using FMN Measured in Perfusate and Bile During Normothermic Machine Perfusion". Discarded perfusate samples will be collected from donors after circulatory death (DCD) or donors after brain death (DBD) organs during the machine perfusion period prior to transplantation by the study team. FMN will be measured as is standard of care for all machine perfusion liver transplant case...
What is the current status of trial NCT07315204?
This trial is currently recruiting. The enrollment target is 850 participants. The study started on 2025-12-29. Estimated completion is 2028-12-31.
What conditions does trial NCT07315204 study?
This clinical trial studies the following conditions: Liver Transplant Disorder.
Who is sponsoring clinical trial NCT07315204?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07315204 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.